Skip to main content
Translational Psychiatry logoLink to Translational Psychiatry
. 2022 Jun 22;12:258. doi: 10.1038/s41398-022-02021-w

The evolution of BDNF is defined by strict purifying selection and prodomain spatial coevolution, but what does it mean for human brain disease?

Alexander G Lucaci 1,#, Michael J Notaras 2,#, Sergei L Kosakovsky Pond 1, Dilek Colak 2,3,
PMCID: PMC9217794  PMID: 35732627

Abstract

Brain-Derived Neurotrophic Factor (BDNF) is an essential mediator of brain assembly, development, and maturation. BDNF has been implicated in a variety of brain disorders such as neurodevelopmental disorders (e.g., autism spectrum disorder), neuropsychiatric disorders (e.g., anxiety, depression, PTSD, and schizophrenia), and various neurodegenerative disorders (e.g., Parkinson’s, Alzheimer’s, etc.). To better understand the role of BDNF in disease, we sought to define the evolution of BDNF within Mammalia. We conducted sequence alignment and phylogenetic reconstruction of BDNF across a diverse selection of >160 mammalian species spanning ~177 million years of evolution. The selective evolutionary change was examined via several independent computational models of codon evolution including FEL (pervasive diversifying selection), MEME (episodic selection), and BGM (structural coevolution of sites within a single molecule). We report strict purifying selection in the main functional domain of BDNF (NGF domain, essentially comprising the mature BDNF protein). Additionally, we discover six sites in our homologous alignment which are under episodic selection in early regulatory regions (i.e. the prodomain) and 23 pairs of coevolving sites that are distributed across the entirety of BDNF. Coevolving BDNF sites exhibited complex spatial relationships and geometric features including triangular relations, acyclic graph networks, double-linked sites, and triple-linked sites, although the most notable pattern to emerge was that changes in the mature region of BDNF tended to coevolve along with sites in the prodomain. Thus, we propose that the discovery of both local and distal sites of coevolution likely reflects ‘evolutionary fine-tuning’ of BDNF’s underlying regulation and function in mammals. This tracks with the observation that BDNF’s mature domain (which encodes mature BDNF protein) is largely conserved, while the prodomain (which is linked to regulation and its own unique functionality) exhibits more pervasive and diversifying evolutionary selection. That said, the fact that negative purifying selection also occurs in BDNF’s prodomain also highlights that this region also contains critical sites of sensitivity which also partially explains its disease relevance (via Val66Met and other prodomain variants). Taken together, these computational evolutionary analyses provide important context as to the origins and sensitivity of genetic changes within BDNF that may help to deconvolute the role of BDNF polymorphisms in human brain disorders.

Subject terms: Genetics, Neuroscience

Introduction

Brain-derived neurotrophic factor (BDNF) is one of the most ubiquitously studied molecules in modern neuroscience [1]. BDNF is a neurotrophin that binds with high affinity to its cognate tyrosine kinase receptor, TrkB [2], to elicit rapid induction of synaptic plasticity [35] and neuronal spine remodeling [6, 7]. Additionally, BDNF has been implicated in a variety of brain disorders [1], including depression [810], PTSD [1114], schizophrenia [9, 1517], Parkinson’s disease [18, 19], and autism spectrum disorders [2022] amongst many more. BDNF has correspondingly been the primary target, or an ancillary factor, of many novel therapeutics including small molecule mimetics [23, 24] and existing drugs (e.g., antidepressants [25, 26]). Yet, nascent research has provided the humbling reminder that much remains to be discovered about BDNF. In recent years, new BDNF ligands have been discovered [27], new receptor interactions unveiled [27, 28], and mechanisms of behavioral function unlocked [7]. This is a timely reminder that while BDNF has remained a seminal molecule of interest across the broader neuroscience literature, much remains to be discovered about its origins, evolution, function, and disease relevance.

A primer of the molecular biology of BDNF and its functional topology

BDNF is encoded by the BDNF gene [29], whose expression is regulated in humans by an antisense gene (BDNF-AS) that can form RNA-duplexes to attenuate translation [30]. Thus, the natural antisense for BDNF is capable of directly downregulating endogenous expression on demand [31]. The BDNF gene in humans comprises 11 exons [30] and can produce at least 17 detectable transcript isoforms [29]. Different transcripts are induced in response to activity and/or cellular states, allowing the BDNF gene to adjust to environmental stimuli and potential selection pressures. However, all transcripts ultimately yield a singular preproBDNF protein that (prior to intracellular processing, cleavage, and transport) can be partitioned into three domains [11, 29]: a signal peptide, a prodomain, and the mature domain. The signal domain is only 18 amino acid residues long (with ambiguously defined functionality) with the majority of BDNFs functional outputs reflecting sequence specificity to the prodomain and mature domain. The BDNF prodomain encodes binding sites for intracellular transport of both BDNF mRNA [32] and BDNF protein [33], and contains numerous posttranslational modification sites [29]. The BDNF prodomain is also the resident location of a widely studied Single Nucleotide Polymorphism (SNP) in neuroscience (Val66Met, or rs6265) [1], and the Furin consensus sequence (Arg 125) for cleavage to its mature form (including by plasmin [34]). The prodomain is composed of 110 amino acids within the N-terminus, and must be processed via proteases to generate mature BDNF [5]. The mature domain of BDNF is almost exclusively composed of the Nerve growth factor (NGF) domain and is responsible for the canonical trophic actions associated with BDNF (e.g., long-term potentiation, rapid-acting antidepressant effects, etc.). Following intracellular handling, processing, and transport, the preproBDNF isoform is cleaved to yield the mature BDNF peptide (which only contains the mature NGF domain). For many years the prodomain was thought to be degraded following the facilitation of BDNF trafficking. However, recent work has shown that the cleaved prodomain can be secreted and bind as a ligand to novel receptors (e.g., SorCS2) [27]. Thus, the BDNF prodomain can influence brain circuits as well as behavior [7]. For a comprehensive, detailed, analysis of the various intricacies of the BDNF gene, protein, and its regulation, more information is provided in [29].

The conservation of BDNF and neurotrophins: a signal that evolution is important

One of the interesting curiosities surrounding BDNF is its relationship to other neurotrophic (NT) growth factors, comprising NGF, NT-3, and NT-4. Specifically, all neurotrophins retain some intercalated functionality. Neurotrophins also share some commonalities in structure (pre-, pro-, and mature-domains) [29], posttranslational modification potential (e.g., glycosylation [35]), as well as catalytic processing, trafficking, and composition [36]. Specifically, neurotrophins share approximately 50% sequence homology [29], and a comparison of domains and motifs reveals that each comprises a prototypic NGF domain as the principal component of the mature pro-growth peptide (see PFAM database [37]). While each neurotrophin elicits functionality via binding to cognate receptors, neurotrophins also exhibit cross-affinity amongst neurotrophin receptors [38] presumably due to their high rates of structural homology. Not surprisingly then, there is some redundancy in the trophic effects of neurotrophins, yet each still maintains nuanced functionality which remains specific to each factor during central nervous system development [39]. Differences in the evolution and temporal dynamics of regulatory sequences, which target gene products to specific destinations within cell-compartments (e.g., dendrites) [40] or to processing routes (e.g., the activity-dependent release pathway) which alter secretory dynamics and/or bioavailability [41], likely contribute to both similarities and differences between neurotrophins. However, almost nothing is known about how the BDNF prodomain has evolutionarily adapted to specifically regulate BDNF dynamics. While evolution has almost certainly shaped the sequences, structure, and function of BDNF, the modeling of such remains relatively unexplored but could provide important insight into the phylogenetic evolutionary history of BDNF, its selection pressure sensitivity across lineages, and quantitative metrics of evolutionary change across species.

Purpose of this Study

Here, we use computational methods to explore the molecular evolution of BDNF. To reconstruct phylogenetic trees of BDNF, we utilized sequence alignments of over 160 mammalian species (all available mammalian sequences) to determine the genomic attributes of BDNF evolution that are specific to Mammalia. This analysis was specific by being constrained to sequences that have the most direct evolutionary relevance to humans. Notably, we sought to identify sites in BDNF that are subject to pervasive (i.e., consistently across the entire phylogeny) diversifying selection (FEL) or pervasive/episodic (i.e., only on a single lineage or subset of lineages, diversifying selection (MEME). Likewise, utilizing multiple models for the inference of selective pressure and the evaluation of evolutionary change, we identify novel sites within the BDNF prodomain and mature peptide coding regions that are susceptible to synonymous and nonsynonymous changes. Additionally, we investigate which sites in BDNF may be coevolving (BGM). Taken together, these computational evolutionary analyses provide an important context as to the origins and sensitivity of genetic changes within the BDNF gene, which may be important for providing insight into genetic risk factors linked to disease in humans.

Results

We find that unique evolutionary pressures have shaped the BDNF gene across time. These forces have mostly operated through strict purifying selection. Of note, BDNF elicits tight regulation and specific functionality that can be separated from other neurotrophins, yet these growth factors remain closely related in their structure and sequence, especially in the conserved NGF domain.

Evolutionary history of mammalian BDNF

Prior to conducting our primary evolutionary analysis, we ported our mammalian species into a platform (timetree.org, see refs. [42, 43]) to examine the epoch events that may have influenced the analysis described here. This was an important pre-analysis step to frame the age of our genomes, and the broad-stroke evolutionary pressures that these species have been exposed to (which, in theory, could contribute to subsequent purifying selection and coevolution analyses). As expected, this revealed BDNF as an ancient gene that has been preserved throughout the mammalian lineage and has both survived and been shaped under all major evolutionary events of the past ~177 million years (data not shown). We identified several examples of species-level evolutionary epochs that cross-referenced with major earth events (e.g., bottleneck events) that have historically been believed to drive evolutionary adaptation. This included major geologic periods that are cross-referenced against earth impacts, oxygenation changes across time, atmospheric carbon dioxide concentrations, and solar luminosity. This indicates that even under extreme evolutionary pressures, the BDNF gene has exhibited (relatively speaking) very specific adaptation events (see results below) over millions of years within Mammalia. This tracks with the idea that “old genes” tend to be highly conserved, evolve more slowly, and therefore are more likely to exhibit both specific and selective changes as opposed to more dramatic permutations (e.g., gene duplications, etc.).

Predominant purifying selection in BDNF

A common approach to gain an increased understanding of the evolutionary forces that have shaped proteins is to measure the omega ratio ω consisting of the nonsynonymous (β or dN) and synonymous (α or dS) substitution rates, with ω = β/α for each site in a particular gene of interest [44]. We define two major changes for the amino acid being coded for at each site: synonymous changes, which keep the same amino acid coded for at a particular site, and nonsynonymous changes, which change the amino acid coded for at a particular site. Non-synonymous changes can have strong influences on the structural, functional, and fitness measures of an organism. This is in contrast to synonymous changes which leave the amino acid at a particular site unchanged but can confer weak fitness effects through the emergent properties of codon usage bias, mRNA structural stability, translation, and tRNA availability. However, synonymous changes are typically understood to represent neutral selection acting on coding sequences and provide a baseline rate against which nonsynonymous evolutionary rates can be compared. The omega ratio ω of relative rates of nonsynonymous and synonymous substitutions is a common measure in evolutionary biology of the selective pressure acting on protein-coding sequences. These estimates provide increased information availability as to the type of selection (positive, with omega >1 or negative, with omega <1, or neutral with omega =1) that has acted upon any given set of protein-coding sequences.

As FEL analysis is a sensitive measure of negative (purifying) selection, for this analysis we observe a predominant amount of purifying selection (over 66% of sites, 174 sites out of 261; Table S1) in our recombination-free alignment for BDNF. The dN/dS estimates for the entire alignment were plotted including 95% lower- and upper-bound estimates (see Fig. 1 or Table S1). Overwhelmingly, the mature NGF domain of the BDNF exhibited evidence of greater pervasive negative purifying selection relative to the prodomain region of BDNF. Thus over the evolutionary history of Mammalia, negative selection has predominantly occurred in the regions of BDNF that encode the functional mature protein that binds TrkB to elicit neurotrophic effects. The mature domain of BDNF has exhibited remarkable conservation across innumerous epochs that have been defined by rapid evolutionary adaptation in other genes and taxa.

Fig. 1. Mammalian BDNF exhibits overwhelmingly strict purifying selection, but also evidence of specific evolutionary pressures at particular sites.

Fig. 1

The FEL analysis of the BDNF gene found 174 of 261 (66.7%) sites to be statistically significant (LRT p value ≤ 0.1) for pervasive negative (purifying) selection. We plot the estimated values of omega (dN/dS) for each site in the alignment. Additionally, we plot 95% confidence intervals (CI) for each site. These results are also available in Table S1. We observe a high degree of strict purifying selection in the Human NGF region. The region for Human NGF corresponds to alignment sites 144–254 (NP_001700.2 and https://github.com/aglucaci/AnalysisOfOrthologousCollections/blob/main/tables/BDNF/BDNF_AlignmentMap.csv). This alignment of BDNF across all selected species (Mammalia, see Table 3) reveals a site-specific positive/adaptive diversifying selection and negative purifying selection. The thick line represents the point estimate (i.e., the evolutionary pressure) and the shadings reflect 95% confidence intervals which relate to the upper and lower bound of the point estimates. As shown, the prodomain sites exhibit more pervasive/episodic and positive/diversifying evolutionary selection, consistent with the fact that more disease-associated SNPs occur in this topological region of the BDNF gene in humans (early prodomain mapping not further shown due to nuanced variation across mammalian species).

Specific sites that are evolving non-neutrally

To examine specific sites for episodic adaptive evolutionary selection, we utilized an algorithm known as MEME which is fundamentally similar to our FEL analysis (described above) except that it applies a more sensitive method for the detection of both pervasive (persistent) and episodic selection (transient selection occurring only on one or a subset of branches in the phylogenetic tree) as compared to only pervasive selection which occurs across all branches of the phylogenetic tree. Essentially, only a subset of the lineages (i.e., species) are affected allowing for a more granular/sensitive method of detecting selection (whereas FEL is better geared towards broad changes). This analysis revealed that for all sites, only 2.3% (6 of 261; see Table 1) exhibit evidence for episodic diversifying selection (i.e., positive selection) in at least one branch within the phylogeny. Spatially, these mutations occur outside of the NGF functional region of BDNF. Further, this result is essentially relevant as the MEME analysis is a sensitive measure of episodic selection. The sites we observe as statistically significant were 26, 27, 30, 38, 249, and 254. For comparison, these specific sites were realigned to the respective human sites with indel (insertion/deletion) events accounting for any respective discrepancy in specific site numbers. When mapping these sites to the human BDNF coordinate system, they correspond to sites 26, 27, 29, 36, 238, and 240, respectively.

Table 1.

MEME analysis of the BDNF gene found 6 of 261 (2.3%) of sites to be statistically significant (LRT p value ≤ 0.1).

# CodonSite Human CodonSite alpha beta- p- beta+ p+ LRT p value # branches under selection MEME LogL FEL LogL Omega
1 26 26 0.14 0.00 0.02 1.12 0.98 6.89 0.01 9 −86.53 −86.53 7.9
2 27 27 0.25 0.08 0.99 28.91 0.01 4.30 0.05 1 −39.25 −37.01 117.6
3 30 29 0.00 0.00 0.00 0.38 1.00 4.63 0.05 6 −35.88 −35.88 inf
4 38 36 0.72 0.00 0.93 8.07 0.07 3.80 0.07 5 −69.22 −66.28 11.3
5 249 238 0.92 0.00 0.99 203.11 0.01 8.25 0.01 1 −50.74 −44.13 221.6
6 254 240 0.23 0.00 0.99 1357.12 0.01 21.81 0.00 1 −44.50 −31.95 5850.4

Evidence of coevolutionary forces

To examine the coevolution of sites, i.e., if one particular amino acid was evolving in-tandem with another, we subjected our protein-coding gene sequences to the BGM algorithm which leverages Bayesian graphical models [45]. The BGM algorithm infers substitution history through the use of maximum-likelihood analyses for ancestral sequences and maps these to the phylogenetic tree, which allows for the detection of correlated patterns of substitution [45]. For our BGM analysis, we find evidence for 23 pairs of coevolving sites. This suggests interaction dynamics in tertiary space of the 3D, folded, protein level (see relevant sites in Fig. 2) BDNF protein structure. Alternatively, this data may be evidence that coevolving sites may be related to other fitness consequences (e.g., compensation) for maladaptive changes in another part of the protein sequence that may have occurred. When we review these sites, we notice that several pairs (see Fig. 2) occur within alignment sites, which correspond to the Human BDNF coordinate system (Table 1). These include pair-sites of (89, 184), (94, 155), (103, 233), and (135, 154). Of note, several other sites also display interesting geometric features including triangular relations [(81, 93), (93, 98), and (81, 98)], an acyclic graph network of site connections [(70, 74), (74, 94), (94, 155) and (25, 49), (49, 85), (49, 86)], more complex double-linked coevolutionary sites [(39, 103) and (103, 233)], and triple-linked coevolutionary sites [(30, 119), (33, 119), and (91, 119)]. Additionally, three-dimensional reconstruction—here focusing on a specific heterodimer configuration of BDNF and NT-4 as an example of a spatial protein–protein interaction—highlights that coevolving sites, as well as positively evolving sites, are likely to have been fine-tuned over time to help support BDNF’s cognate functionality (see Fig. 3). Mapping our FEL purifying sites in a structural configuration was not shown due to the overwhelming nature of negative selection acting on BDNF within mammals.

Fig. 2. The BGM analysis of BDNF found 23 pairs of coevolving sites out of 261 total sites to be statistically significant (with a posterior probability threshold of 0.5).

Fig. 2

Here, we plot only the statistically significant coevolving pairs. The number of shared substitutions between pairs of coevolving sites is visualized by the size of the circle, with larger circles indicating more shared substitutions. Poster probability of the interaction (coevolving pair) corresponds to the color blue, with dark blue indicating higher values. Individual BDNF sites are mapped on both the X and Y axis so that readers can view which sites are coevolving with another. Once more, note that the coevolution tends to be focally constrained to the broader BDNF prodomain region at a topological level, which is once more consistent with the idea that the NGF domain (site >144; see Fig. 3) is highly conserved and probably deleteriously impacted by variation. However, we did discover four sites of coevolution in the NGF domain (basically, the mature BDNF protein) that are evolving with early prodomain sites. This highlights that both proximal and distal sites in BDNF can, and indeed are, evolving together over time.

Fig. 3. BDNF NT-4 heterodimer structural analysis to highlight coevolving and adaptive sites at the 3D protein level.

Fig. 3

Demonstrating the structural configuration of the BDNF (blue) and NT-4 (pink) heterodimer (see https://www.rcsb.org/structure/1B8M), with rotations (arbitrary degrees) shown to accentuate the view of coevolving sites (orange, see also Fig. 2 and Table 2) and positively evolving sites (red; see Table 1). The PDB structure is limited to the NGF domain which limits our ability to highlight sites of interest (SOI), therefore we have limited our annotation only to the modeled sites in the structure. The relative positioning of coevolving and positively evolving sites in this heterodimer visualization are in proximity to looping and other macro tertiary structures of protein. An interactive figure that is rotatable in 3D space, where occupations occur in three dimensions (i.e., teasing out relative proximity in 2D linear space), is available here: https://observablehq.com/@aglucaci/bdnf-structure.

Discussion

In this study, we explore the evolutionary history of the BDNF gene in Mammalia. The BDNF gene is implicated in a number of human diseases including a variety of brain disorders such as neurodevelopmental disorders (e.g., autism spectrum disorder), neuropsychiatric disorders (e.g., depression, PTSD, and schizophrenia), and some neurodegenerative disorders [1]. By using orthologous BDNF sequences within the Mammalia taxonomic group, our results indicate that unique site-specific changes within BDNF have evolved over time. We performed a number of comparative evolutionary analyses to tease out signals from our orthologous gene collection in BDNF. Of note, the BDNF gene elicits tight regulation and specific functionality that can be separated from other neurotrophins, yet these growth factors remain closely related in their structure and sequence and conservation of the NGF functional domain. In the NGF domain, we observe a high degree of conservation (via purifying selection) across species, owing to the functional importance of this region in protein–protein interactions. This work additionally provides broad comparative insights into the evolutionary history of the BDNF gene family. Our MEME method identified novel substitutions (see Table 1) in regions of BDNF that may provide significant areas of interest for designing molecular therapeutic approaches, and their potential broader significance are outlined in further detail below.

Predominant purifying selection across BDNF in Mammalia

Over time, evolution drives the divergence of genetic sequences, but what can we learn from the direct comparison of the sequences of the BDNF gene in Mammalia? By comparing the BDNF products of orthologous sequences in different species, we observe the accumulation of mutations at different sites with varying degrees of insight into both BDNF functionality (see [29] for site annotation) and potential disease [1]. These are summarized in full within Table S1 and Table 1. Coding sequences with highly constrained structures are expected to fix nonsynonymous mutations at a slower rate due to the maladaptive nature of changes such as what we observe with FEL negatively selected sites across BDNF. Additionally, we observe a high degree of negative (purifying) selection across the main functional domain (NGF) of BDNF. While structures for the NGF domain in most species under analysis do not exist, based on our findings we expect a highly conserved tertiary structure. Based on the high degree of purifying selection observed across BDNF, we hypothesize that BDNF plays a critical role in the underlying network of genes governing homeostasis and normal organismal development. This may have happened because BDNF is particularly useful specifically for the phylogenetic branch in question (i.e., mammals). This interpretation is also consistent with the observation that BDNF is essential for normative development and is lethal in non-conditional full knock-out mammalian models.

Non-neutral positive diversifying evolution sites in the BDNF gene

It has been described that BDNF plays a particular role as a foundational gene for brain development [11]. Despite a significant level of purifying selection shaping the evolutionary history of BDNF (Fig. 1), we observe several novel statistically significant sites under positive episodic diversifying selection across the BDNF gene (see Table 1). Traditionally, the evolution of this variety consists of amino acid diversifying events that may promote phylogenetic adaptation and/or functionality. These results are entirely novel—they have not been previously reported (to the best of our knowledge) and MEME is an established and sensitive method for the analysis of episodic diversifying sites. Thus, the very specific and limited sites within BDNF to exhibit such patterns is a highly promising result from which to further disentangle BDNF's complex functionality and disease linkage. We would encourage biologists to consider these sites as those that may contain important adaptive functions within the BDNF gene. However, where our results fall within the context of a core protein–protein interaction network of required genes for neural cellular diversity and development is yet to be determined. We do note that at least one identified site (238) overlaps with potential posttranslational modifications to the human BDNF peptide (specifically, a disulfide bridge; see UniProt and [29]). This supports the idea that non-neutral positive diversifying sites within BDNF are not spurious and likely reflect specialized, regulatory, or functional capacities that may have yet to be annotated in full. Given that this manuscript is devoted to the analysis of BDNF’s evolution in mammals, we highlight the potential importance of these sites but emphasize that their importance remains a hypothesis that should be tested in well-defined experiments under controlled laboratory conditions.

Discovery of proximal and distal coevolving site-pairs in the BDNF gene

Another novel, and potentially important, series of findings in this manuscript was the presence of numerous sites that exhibit coevolution. In fact, we observe a significant number of coevolving sites within the BDNF gene (see Fig. 2 and Table 2), and these too reflect an entirely novel aspect of BDNF biology that has not previously been reported. Evidence of coevolving sites are not limited to a particular domain (e.g., prodomain vs mature) nor specific motifs. Instead, coevolving pairs seem to be distributed across the entirety of BDNF with, perhaps unsurprisingly, an increased density of interactions early in the prodomain region. However, we also note that there are coevolving sites in the mature NGF domain which are “linked” to early domain sites. Importantly, these relationships may confer strong epistatic interactions shaping the continued evolution of this critically important gene. The new evidence for coevolution may point to the importance of these sites in shaping the early regulatory or main functional (NGF) domain of BDNF. These residues may form important interactions for the functional integrity of BDNF and, importantly, the highly specific pairs which span the BDNF prodomain and its mature region point to a new mechanism by which the BDNF prodomain may have coregulated the mature domain (or vice versa). Alternatively, these coevolving pairs may be part of a network of residues occupying a shifted fitness landscape in order to accommodate new or species-specific functional requirements.

Table 2.

The BGM analysis of BDNF found 23 pairs of coevolving sites out of 261 total sites to be statistically significant (with a posterior probability threshold of 0.5).

# Site 1 Site 2 P [Site 1 –> Site 2] P [Site 2 –> Site 1] P [Site 1 < –> Site 2] Site 1 subs Site 2 subs Shared subs
1 5 67 0.52 0.32 0.84 1 1 1
2 25 49 0.022 0.67 0.69 8 6 3
3 27 109 0.12 0.45 0.57 2 1 1
4 30 119 0.2 0.56 0.75 6 12 4
5 33 119 0.12 0.72 0.84 3 12 3
6 39 103 0.22 0.58 0.8 8 4 3
7 49 85 0.48 0.049 0.53 6 3 2
8 49 86 0.36 0.55 0.91 6 5 3
9 50 69 0.31 0.27 0.58 1 2 1
10 62 64 0.25 0.27 0.52 1 1 1
11 70 74 0.17 0.38 0.55 7 14 4
12 70 95 0.59 0.26 0.85 7 21 5
13 74 94 0.034 0.64 0.68 14 7 4
14 78 90 0.46 0.38 0.84 1 1 1
15 81 93 0.27 0.31 0.58 1 1 1
16 81 98 0.27 0.33 0.61 1 1 1
17 82 91 0.045 0.92 0.96 15 29 9
18 89 184 0.24 0.5 0.74 2 6 2
19 91 119 0.22 0.67 0.89 29 12 8
20 93 98 0.31 0.3 0.61 1 1 1
21 94 155 0.28 0.29 0.57 7 2 2
22 103 233 0.4 0.13 0.53 4 3 2
23 135 154 0.4 0.43 0.82 1 1 1

Potential structural implications of evolving sites

In considering our observation of both diversifying selection and coevolving sites in the BDNF gene, we considered the potential implications this may have at a protein structural level in three-dimensional space (see Fig. 3). While protein structural impacts from evolution remain poorly understood and cannot be completely experimentally disentangled in a confirmatory sense, the implications fall upon our understanding of basic BDNF neurobiology. Here we note that our BGM and FEL analyses implicate the prodomain—the primary topological region of BDNF known for polymorphic variability (e.g., Val66Met and Gln75His) that is often linked to disease [1, 11, 29], and our 3D modeling suggests that two of our coevolving sites appear to be associated with looping structures that could have important yet to be discovered functionality. In this regard, we predict that the evolutionary changes described here are likely to reflect some form of specialization and/or divergence in function and/or interaction partners at different points of BDNF’s evolutionary history in mammals. Thus, further work may unveil yet more novel sites that could provide further insight into the origins of BDNF’s diverse functionality and its role in disease.

Limitations of our computational evolutionary analysis

This analysis focused on BDNF sequences contained in the taxonomic group Mammalia in lieu of examining a more inclusive dataset for BDNF containing sequences from all of Gnathostomata (jawed vertebrates) or extension into invertebrate clades which may contain BDNF or BDNF-like analog genes. Our results are applicable to mammals, which are our intentional taxonomic group of study, but we nonetheless emphasize that our results do not capture the entirety of BDNF’s evolutionary history (e.g., there could be more to learn about BDNF from birds, lizards, fish, and higher-order taxonomic groups which we do not evaluate here). In addition, we do not explore the patterns or mutational processes occurring outside of coding-sequence evolution which include complex structure and dynamics of non-coding regions in the BDNF gene. Therefore, evolutionary temporality is important in the context and interpretation of our results because Mammalia represents only a portion of the long evolutionary history of BDNF. Although we failed to find evidence for recombination in our dataset, species where we may find evidence for recombination may have been precluded from our analysis due to our decision to focus on mammalian BDNF evolution. Further, a limitation of the current analysis is owed to the presence of indel events, especially in the early region of the alignment but which also occur in other spatially distributed regions of the BDNF gene. These indel events are not currently modeled in existing codon substitution models but may represent an additional pathway of evolutionary change. Nonetheless, the prominence of indels in our observations indicates that several regions of BDNF may evolve significantly through indel events across species. Lastly, although there is a risk that the “gappy” nature of the early region of our multiple sequence alignment may be a computational artifact of the alignment procedure, based on all other outputs we believe that our results are reasonably interpreted and have subsequently tolerated these potential effects.

Future directions: understanding the remainder of the neurotrophin family

We hypothesize that the similarities between neurotrophins reflects conserved evolutionary selection for motifs and domains which support common functionality in neurotrophic factors between sites and lineages. While we note significant isotropy in mature peptide sequences for these factors, anisotropic pressures likely influenced the prodomain sequences of neurotrophins leading to alterations in processing, trafficking, regulation, and secretion. As such, we also predict differences in the evolutionary fate of other neurotrophins which also exhibit compartmentalized functionality due to similar alterations within their prodomains (i.e., similar results may be reasonably anticipated in NGF, NT-3, and NT-4).

Conclusion

To sum up, our research modeled the natural evolutionary history of changes in BDNF across >160 mammalian genomes. Conservatively, this analysis spans ~177 million years of evolution—and going deeper could yet reveal more information on the ontogenesis of BDNF and its topological structure (and, consequently, function). Notably, we observed strict purifying selection in the main functional domain of the BDNF gene in mammals and discovered 6 specific sites in our homologous alignment that are under episodic selection in the early regulatory region of BDNF (i.e., the prodomain) and in the terminal region of BDNF. We also make the case for spatial coevolution within this gene, with 23 pair-sites that have evolved together. In sum, these data go above and beyond the common trope that “BDNF is highly conserved” by defining exactly where and how the mammalian BDNF has evolved. Thus, we confirm the widespread belief that the BDNF prodomain is more prone to change than the mature BDNF protein, having important implications for how we think about and consider genetic variation in BDNF and its linkage to disease.

Methods

Data retrieval

For this study, we queried the NCBI Ortholog database via https://www.ncbi.nlm.nih.gov/kis/ortholog/627/?scope=7776. For the purpose of this study, as we are interested in mammalian BDNF evolution, we limited our search to only include species from this taxonomic group (mammals, Mammalia). This returned 162 full gene transcripts and protein sequences. We downloaded all available files: RefSeq protein sequences, RefSeq transcript sequences, Tabular data (CSV, metadata). In Table 3, we provide a table of the species included in this analysis but we also make this accessible via GitHub. Furthermore, we also make these species NCBI accessions (see also Table 3) available for download on GitHub:

Table 3.

Tabulation of species included in our analysis, comprising NCBI ortholog gene IDs, symbols, mammalian species, common name, and RefSeq accessions.

Gene ID Gene symbol Description Scientific name Common name RefSeq transcript accessions RefSeq protein accessions
627 BDNF brain-derived neurotrophic factor Homo sapiens human NM_001709.5 NP_001700.2
12064 Bdnf brain-derived neurotrophic factor Mus musculus house mouse NM_001048142.1 NP_001041607.1
24225 Bdnf brain-derived neurotrophic factor Rattus norvegicus Norway rat NM_001270630.1 NP_001257559.1
397495 BDNF brain-derived neurotrophic factor Sus scrofa pig XM_005654684.3 XP_005654741.1
403461 BDNF brain-derived neurotrophic factor Canis lupus familiaris dog XM_038429434.1 XP_038285362.1
493690 BDNF brain-derived neurotrophic factor Felis catus domestic cat NM_001009828.1 NP_001009828.1
503511 BDNF brain-derived neurotrophic factor Pan troglodytes chimpanzee NM_001012441.1 NP_001012443.1
554233 BDNF brain-derived neurotrophic factor Monodelphis domestica gray short-tailed opossum XM_007497196.2 XP_007497258.1
617701 BDNF brain-derived neurotrophic factor Bos taurus cattle XM_005216334.4 XP_005216391.1
701245 BDNF brain-derived neurotrophic factor Macaca mulatta Rhesus monkey XM_015114598.2 XP_014970084.1
100009689 BDNF brain-derived neurotrophic factor Equus caballus horse NM_001081787.1 NP_001075256.1
100081142 BDNF brain-derived neurotrophic factor Ornithorhynchus anatinus platypus XM_029059317.2 XP_028915150.1
100356949 BDNF brain-derived neurotrophic factor Oryctolagus cuniculus rabbit XM_017345633.1 XP_017201122.1
100409412 BDNF brain-derived neurotrophic factor Callithrix jacchus white-tufted-ear marmoset XM_009007854.3 XP_009006102.1
100447350 BDNF brain-derived neurotrophic factor Pongo abelii Sumatran orangutan XM_002821931.2 XP_002821977.1
100467162 BDNF brain-derived neurotrophic factor Ailuropoda melanoleuca giant panda XM_011226480.3 XP_011224782.2
100594402 BDNF brain-derived neurotrophic factor Nomascus leucogenys northern white-cheeked gibbon XM_003254347.2 XP_003254395.1
100667885 BDNF brain-derived neurotrophic factor Loxodonta africana African savanna elephant XM_023550772.1 XP_023406540.1
100730257 Bdnf brain-derived neurotrophic factor Cavia porcellus domestic guinea pig XM_013147262.2 XP_013002716.1
100768664 Bdnf brain-derived neurotrophic factor Cricetulus griseus Chinese hamster XM_007653166.4 XP_007651356.1
100934810 BDNF brain-derived neurotrophic factor Sarcophilus harrisii Tasmanian devil XM_031944159.1 XP_031800019.1
100958946 BDNF brain-derived neurotrophic factor Otolemur garnettii small-eared galago XM_012814047.1 XP_012669501.1
100983866 BDNF brain-derived neurotrophic factor Pan paniscus pygmy chimpanzee XM_034932318.1 XP_034788209.1
101007866 BDNF brain-derived neurotrophic factor Papio anubis olive baboon XM_017948537.3 XP_017804026.1
101037414 BDNF brain-derived neurotrophic factor Saimiri boliviensis Bolivian squirrel monkey XM_003919940.3 XP_003919989.2
101117275 BDNF brain-derived neurotrophic factor Ovis aries sheep XM_012096129.4 XP_011951519.2
101134399 BDNF brain-derived neurotrophic factor Gorilla gorilla western gorilla XM_004050851.2 XP_004050899.1
101281702 BDNF brain-derived neurotrophic factor Orcinus orca killer whale XM_004263941.3 XP_004263989.1
101338565 BDNF brain-derived neurotrophic factor Tursiops truncatus common bottlenose dolphin XM_019947883.2 XP_019803442.1
101350169 LOC101350169 brain-derived neurotrophic factor Trichechus manatus latirostris Florida manatee XM_004369733.1 XP_004369790.1
101372507 BDNF brain-derived neurotrophic factor Odobenus rosmarus divergens Pacific walrus XM_004408653.1 XP_004408710.1
101398458 LOC101398458 brain-derived neurotrophic factor Ceratotherium simum simum southern white rhinoceros XM_004418542.2 XP_004418599.1
101428552 BDNF brain-derived neurotrophic factor Dasypus novemcinctus nine-banded armadillo XM_012523604.2 XP_012379058.1
101528222 BDNF brain-derived neurotrophic factor Ochotona princeps American pika XM_004585440.1 XP_004585497.1
101553155 BDNF brain-derived neurotrophic factor Sorex araneus European shrew XM_004607860.1 XP_004607917.1
101566518 Bdnf brain-derived neurotrophic factor Octodon degus degu XM_004644113.2 XP_004644170.1
101600646 Bdnf brain-derived neurotrophic factor Jaculus jaculus lesser Egyptian jerboa XM_004660846.2 XP_004660903.1
101632951 BDNF brain-derived neurotrophic factor Condylura cristata star-nosed mole XM_004682964.2 XP_004683021.1
101643198 BDNF brain-derived neurotrophic factor Echinops telfairi small Madagascar hedgehog XM_004708253.2 XP_004708310.1
101687038 BDNF brain-derived neurotrophic factor Mustela putorius furo domestic ferret XM_004755891.2 XP_004755948.1
101704465 Bdnf brain-derived neurotrophic factor Heterocephalus glaber naked mole-rat XM_004851581.3 XP_004851638.1
101837384 Bdnf brain-derived neurotrophic factor Mesocricetus auratus golden hamster XM_005064810.4 XP_005064867.1
101954451 Bdnf brain-derived neurotrophic factor Ictidomys tridecemlineatus thirteen-lined ground squirrel XM_040284582.1 XP_040140516.1
101993181 Bdnf brain-derived neurotrophic factor Microtus ochrogaster prairie vole XM_005364052.2 XP_005364109.1
102016703 Bdnf brain-derived neurotrophic factor Chinchilla lanigera long-tailed chinchilla XM_005401751.2 XP_005401808.1
102126294 BDNF brain-derived neurotrophic factor Macaca fascicularis crab-eating macaque XM_005578346.2 XP_005578403.1
102180782 BDNF brain-derived neurotrophic factor Capra hircus goat XM_005690025.2 XP_005690082.2
102247090 BDNF brain-derived neurotrophic factor Myotis brandtii Brandt’s bat XM_014545223.1 XP_014400709.1
102279714 BDNF brain-derived neurotrophic factor Bos mutus wild yak XM_005890667.2 XP_005890729.1
102395046 BDNF brain-derived neurotrophic factor Bubalus bubalis water buffalo XM_006068006.2 XP_006068068.1
102440705 BDNF brain-derived neurotrophic factor Myotis lucifugus little brown bat XM_023756374.1 XP_023612142.1
102475289 BDNF brain-derived neurotrophic factor Tupaia chinensis Chinese tree shrew XM_014591303.2 XP_014446789.1
102511705 BDNF brain-derived neurotrophic factor Camelus ferus Wild Bactrian camel XM_006195083.3 XP_006195145.1
102532564 BDNF brain-derived neurotrophic factor Vicugna pacos alpaca XM_031681074.1 XP_031536934.1
102730927 BDNF brain-derived neurotrophic factor Leptonychotes weddellii Weddell seal XM_031025064.1 XP_030880924.1
102754946 BDNF brain-derived neurotrophic factor Myotis davidii XM_006753948.2 XP_006754011.1
102839210 BDNF brain-derived neurotrophic factor Chrysochloris asiatica Cape golden mole XM_006864851.1 XP_006864913.1
102870215 BDNF brain-derived neurotrophic factor Elephantulus edwardii Cape elephant shrew XM_006883713.1 XP_006883775.1
102896087 BDNF brain-derived neurotrophic factor Pteropus alecto black flying fox XM_006907988.2 XP_006908050.1
102911929 Bdnf brain-derived neurotrophic factor Peromyscus maniculatus bairdii prairie deer mouse XM_006980818.2 XP_006980880.1
102958723 BDNF brain-derived neurotrophic factor Panthera tigris altaica Amur tiger XM_015544869.1 XP_015400355.1
102977934 BDNF brain-derived neurotrophic factor Physeter catodon sperm whale XM_028501134.1 XP_028356935.1
103017938 BDNF brain-derived neurotrophic factor Balaenoptera acutorostrata scammoni XM_007180991.1 XP_007181053.1
103085069 BDNF brain-derived neurotrophic factor Lipotes vexillifer Yangtze River dolphin XM_007461679.1 XP_007461741.1
103126099 BDNF brain-derived neurotrophic factor Erinaceus europaeus western European hedgehog XM_016194241.1 XP_016049727.1
103206496 BDNF brain-derived neurotrophic factor Orycteropus afer afer XM_007951952.1 XP_007950143.1
103238537 BDNF brain-derived neurotrophic factor Chlorocebus sabaeus green monkey XM_008003703.2 XP_008001894.1
103252117 BDNF brain-derived neurotrophic factor Carlito syrichta Philippine tarsier XM_008050727.1 XP_008048918.1
103292699 BDNF brain-derived neurotrophic factor Eptesicus fuscus big brown bat XM_008148947.2 XP_008147169.1
103552694 BDNF brain-derived neurotrophic factor Equus przewalskii Przewalski’s horse XM_008522855.1 XP_008521077.1
103599960 BDNF brain-derived neurotrophic factor Galeopterus variegatus Sunda flying lemur XM_008584165.1 XP_008582387.1
103659367 BDNF brain-derived neurotrophic factor Ursus maritimus polar bear XM_008686880.2 XP_008685102.2
103748489 Bdnf brain-derived neurotrophic factor Nannospalax galili Upper Galilee mountains blind mole-rat XM_029555090.1 XP_029410950.1
104671126 BDNF brain-derived neurotrophic factor Rhinopithecus roxellana golden snub-nosed monkey XM_010374529.2 XP_010372831.1
104873642 Bdnf brain-derived neurotrophic factor Fukomys damarensis Damara mole-rat XM_033764060.1 XP_033619951.1
104982427 BDNF brain-derived neurotrophic factor Bison bison bison XM_010831788.1 XP_010830090.1
105076551 BDNF brain-derived neurotrophic factor Camelus bactrianus Bactrian camel XM_010964743.1 XP_010963045.1
105106448 BDNF brain-derived neurotrophic factor Camelus dromedarius Arabian camel XM_031459858.1 XP_031315718.1
105293721 BDNF brain-derived neurotrophic factor Pteropus vampyrus large flying fox XM_011362565.2 XP_011360867.1
105463281 BDNF brain-derived neurotrophic factor Macaca nemestrina pig-tailed macaque XM_011710310.2 XP_011708612.1
105507710 BDNF brain-derived neurotrophic factor Colobus angolensis palliatus XM_011936307.1 XP_011791697.1
105528120 BDNF brain-derived neurotrophic factor Mandrillus leucophaeus drill XM_011964715.1 XP_011820105.1
105572781 BDNF brain-derived neurotrophic factor Cercocebus atys sooty mangabey XM_012031697.1 XP_011887087.1
105717219 BDNF brain-derived neurotrophic factor Aotus nancymaae Ma’s night monkey XM_012452238.1 XP_012307661.1
105814556 BDNF brain-derived neurotrophic factor Propithecus coquereli Coquerel’s sifaka XM_012649556.1 XP_012505010.1
105860148 BDNF brain-derived neurotrophic factor Microcebus murinus gray mouse lemur XM_020286534.1 XP_020142123.1
105988089 Bdnf brain-derived neurotrophic factor Dipodomys ordii Ord’s kangaroo rat XM_013019592.1 XP_012875046.1
106824927 BDNF brain-derived neurotrophic factor Equus asinus ass XM_014831462.1 XP_014686948.1
106970278 BDNF brain-derived neurotrophic factor Acinonyx jubatus cheetah XM_027072960.1 XP_026928761.1
107134338 Bdnf brain-derived neurotrophic factor Marmota marmota marmota Alpine marmot XM_015476449.1 XP_015331935.1
107512170 BDNF brain-derived neurotrophic factor Rousettus aegyptiacus Egyptian rousette XM_036221046.1 XP_036076939.1
107531942 BDNF brain-derived neurotrophic factor Miniopterus natalensis XM_016206154.1 XP_016061640.1
108311306 BDNF brain-derived neurotrophic factor Cebus imitator Panamanian white-faced capuchin XM_017538722.1 XP_017394211.1
108401589 BDNF brain-derived neurotrophic factor Manis javanica Malayan pangolin XM_017667612.2 XP_017523101.2
108519651 BDNF brain-derived neurotrophic factor Rhinopithecus bieti black snub-nosed monkey XM_017858805.1 XP_017714294.1
109271282 BDNF brain-derived neurotrophic factor Panthera pardus leopard XM_019456577.1 XP_019312122.1
109387036 BDNF brain-derived neurotrophic factor Hipposideros armiger great roundleaf bat XM_019650718.1 XP_019506263.1
109569212 BDNF brain-derived neurotrophic factor Bos indicus zebu cattle XM_019974522.1 XP_019830081.1
109695020 Bdnf brain-derived neurotrophic factor Castor canadensis American beaver XM_020177315.1 XP_020032904.1
110143608 BDNF brain-derived neurotrophic factor Odocoileus virginianus texanus XM_020903256.1 XP_020758915.1
110202027 BDNF brain-derived neurotrophic factor Phascolarctos cinereus koala XM_020977976.1 XP_020833635.1
110285237 Bdnf brain-derived neurotrophic factor Mus caroli Ryukyu mouse XM_021151236.2 XP_021006895.1
110318089 Bdnf brain-derived neurotrophic factor Mus pahari shrew mouse XM_021192829.2 XP_021048488.1
110576669 BDNF brain-derived neurotrophic factor Neomonachus schauinslandi Hawaiian monk seal XM_021685880.1 XP_021541555.1
111150176 LOC111150176 brain-derived neurotrophic factor Enhydra lutris kenyoni XM_022507574.1 XP_022363282.1
111179820 BDNF brain-derived neurotrophic factor Delphinapterus leucas beluga whale XM_022583733.1 XP_022439441.1
111554690 BDNF brain-derived neurotrophic factor Piliocolobus tephrosceles Ugandan red Colobus XM_023230347.2 XP_023086115.1
112303343 BDNF brain-derived neurotrophic factor Desmodus rotundus common vampire bat XM_024558903.1 XP_024414671.1
112412908 BDNF brain-derived neurotrophic factor Neophocaena asiaeorientalis asiaeorientalis Yangtze finless porpoise XM_024764694.1 XP_024620462.1
112607193 BDNF brain-derived neurotrophic factor Theropithecus gelada gelada XM_025358305.1 XP_025214090.1
112667789 BDNF brain-derived neurotrophic factor Canis lupus dingo dingo XM_025459816.2 XP_025315601.1
112829628 BDNF brain-derived neurotrophic factor Callorhinus ursinus northern fur seal XM_025879326.1 XP_025735111.1
112865997 BDNF brain-derived neurotrophic factor Puma concolor puma XM_025929035.1 XP_025784820.1
112935019 BDNF brain-derived neurotrophic factor Vulpes vulpes red fox XM_026018600.1 XP_025874385.1
113199355 Bdnf brain-derived neurotrophic factor Urocitellus parryii Arctic ground squirrel XM_026412272.1 XP_026268057.1
113265088 BDNF brain-derived neurotrophic factor Ursus arctos horribilis XM_026512203.1 XP_026367988.1
113624889 BDNF brain-derived neurotrophic factor Lagenorhynchus obliquidens Pacific white-sided dolphin XM_027115138.1 XP_026970939.1
113905455 BDNF brain-derived neurotrophic factor Bos indicus x Bos taurus hybrid cattle XM_027562786.1 XP_027418587.1
113913517 BDNF brain-derived neurotrophic factor Zalophus californianus California sea lion XM_027577807.1 XP_027433608.1
114036167 BDNF brain-derived neurotrophic factor Vombatus ursinus common wombat XM_027852578.1 XP_027708379.1
114093712 Bdnf brain-derived neurotrophic factor Marmota flaviventris yellow-bellied marmot XM_027936596.1 XP_027792397.1
114220007 BDNF brain-derived neurotrophic factor Eumetopias jubatus Steller sea lion XM_028117708.1 XP_027973509.1
114500881 BDNF brain-derived neurotrophic factor Phyllostomus discolor pale spear-nosed bat XM_028517638.2 XP_028373439.1
114620789 Bdnf brain-derived neurotrophic factor Grammomys surdaster XM_028766921.1 XP_028622754.1
114702098 Bdnf brain-derived neurotrophic factor Peromyscus leucopus white-footed mouse XM_037204438.1 XP_037060333.1
114886864 BDNF brain-derived neurotrophic factor Monodon monoceros narwhal XM_029207934.1 XP_029063767.1
115306639 BDNF brain-derived neurotrophic factor Suricata suricatta meerkat XM_029957152.1 XP_029813012.1
115525821 BDNF brain-derived neurotrophic factor Lynx canadensis Canada lynx XM_030333208.1 XP_030189068.1
115857612 BDNF brain-derived neurotrophic factor Globicephala melas long-finned pilot whale XM_030864833.1 XP_030720693.1
116090620 Bdnf brain-derived neurotrophic factor Mastomys coucha southern multimammate mouse XM_031371313.1 XP_031227173.1
116476405 BDNF brain-derived neurotrophic factor Hylobates moloch silvery gibbon XM_032166370.1 XP_032022261.1
116555191 BDNF brain-derived neurotrophic factor Sapajus apella tufted capuchin XM_032283691.1 XP_032139582.1
116599082 BDNF brain-derived neurotrophic factor Mustela erminea ermine XM_032358760.1 XP_032214651.1
116638304 BDNF brain-derived neurotrophic factor Phoca vitulina harbor seal XM_032414183.1 XP_032270074.1
116758559 BDNF brain-derived neurotrophic factor Phocoena sinus vaquita XM_032641481.1 XP_032497372.1
116881443 BDNF brain-derived neurotrophic factor Lontra canadensis Northern American river otter XM_032881246.1 XP_032737137.1
116901726 Bdnf brain-derived neurotrophic factor Rattus rattus black rat XM_032903861.1 XP_032759752.1
117029758 BDNF brain-derived neurotrophic factor Rhinolophus ferrumequinum greater horseshoe bat XM_033118944.1 XP_032974835.1
117080419 BDNF brain-derived neurotrophic factor Trachypithecus francoisi Francois’s langur XM_033205475.1 XP_033061366.1
117704234 Bdnf brain-derived neurotrophic factor Arvicanthis niloticus African grass rat XM_034496309.1 XP_034352200.1
118015716 BDNF brain-derived neurotrophic factor Mirounga leonina Southern elephant seal XM_035012477.1 XP_034868368.1
118546649 BDNF brain-derived neurotrophic factor Halichoerus grypus gray seal XM_036109493.1 XP_035965386.1
118582264 Bdnf brain-derived neurotrophic factor Onychomys torridus southern grasshopper mouse XM_036184983.1 XP_036040876.1
118628031 BDNF brain-derived neurotrophic factor Molossus molossus Pallas’s mastiff bat XM_036258707.1 XP_036114600.1
118664943 BDNF brain-derived neurotrophic factor Myotis myotis XM_036325692.1 XP_036181585.1
118713266 BDNF brain-derived neurotrophic factor Pipistrellus kuhlii Kuhl’s pipistrelle XM_036427676.1 XP_036283569.1
118853508 BDNF brain-derived neurotrophic factor Trichosurus vulpecula common brushtail XM_036763631.1 XP_036619526.1
118900201 BDNF brain-derived neurotrophic factor Balaenoptera musculus Blue whale XM_036862552.1 XP_036718447.1
118909009 BDNF brain-derived neurotrophic factor Manis pentadactyla Chinese pangolin XM_036879079.1 XP_036734974.1
118983123 BDNF brain-derived neurotrophic factor Sturnira hondurensis XM_037040421.1 XP_036896316.1
119049902 BDNF brain-derived neurotrophic factor Artibeus jamaicensis Jamaican fruit-eating bat XM_037146035.1 XP_037001930.1
119255407 BDNF brain-derived neurotrophic factor Talpa occidentalis Iberian mole XM_037522538.1 XP_037378435.1
119536361 BDNF brain-derived neurotrophic factor Choloepus didactylus southern two-toed sloth XM_037839114.1 XP_037695042.1
119815449 Bdnf brain-derived neurotrophic factor Arvicola amphibius Eurasian water vole XM_038331579.1 XP_038187507.1
119943514 BDNF brain-derived neurotrophic factor Tachyglossus aculeatus Australian echidna XM_038764545.1 XP_038620473.1
120220096 BDNF brain-derived neurotrophic factor Hyaena hyaena striped hyena XM_039217098.1 XP_039073029.1
120605221 BDNF brain-derived neurotrophic factor Pteropus giganteus Indian flying fox XM_039866065.1 XP_039721999.1
120876831 BDNF brain-derived neurotrophic factor Oryx dammah scimitar-horned oryx XM_040258919.1 XP_040114853.1
121043625 BDNF brain-derived neurotrophic factor Puma yagouaroundi jaguarundi XM_040495572.1 XP_040351506.1
121156520 BDNF brain-derived neurotrophic factor Ochotona curzoniae black-lipped pika XM_040980297.1 XP_040836231.1
121465693 Bdnf brain-derived neurotrophic factor Microtus oregoni creeping vole XM_041679035.1 XP_041534969.1
121476611 BDNF brain-derived neurotrophic factor Vulpes lagopus Arctic fox XM_041730708.1 XP_041586642.1

Data cleaning

We used the protein sequence and full gene transcripts to derive coding sequences (CDS) (via a custom script, scripts/codons.py). However, this process was met with errors in 20 “PREDICTED” protein sequences, which had invalid characters such as sequences, which have incorrect “X”, or unresolved amino acids and these sequences were subsequently exempt from the analysis. This process removes low-quality protein sequences from analysis which may inflate rates of nonsynonymous change.

Analysis of orthologous collections (AOC): alignment, recombination detection, tree inference, and selection algorithms

The analysis of orthologous collections (AOC) application is designed for comprehensive protein-coding molecular sequence analysis (https://github.com/aglucaci/AnalysisOfOrthologousCollections). It accomplishes this through a series of comparative evolutionary methods. AOC allows for the inclusion of recombination detection, a powerful force in shaping gene evolution and interpreting analytic results. As well, it allows for lineage assignment and annotation. This feature (lineage assignment) allows between-group comparisons of selective pressures. This application currently accepts two input files: a protein sequence unaligned fasta file, and a transcript sequence unaligned fasta file for the same gene. Typically, this can be retrieved from public databases such as NCBI Orthologs. Although other methods of data compilation are also acceptable. In addition, the application is easily modifiable to accept a single CDS input, if that data is available.

If protein and transcript files are provided, a custom script “scripts/codons.py” is executed and returns coding sequences where available. Note that this script currently is set to use the standard genetic code, this will need to be modified for alternate codon tables. This script also removes “low-quality” sequences if no match is found, see the above Data cleaning section.

Step 1. Alignment. We used the HyPhy [46] codon-aware multiple sequence alignment procedure available at (https://github.com/veg/hyphy-analyses/tree/master/codon-msa). This was performed with a Human BDNF coding sequence NM_001709.5 Homo sapiens brain-derived neurotrophic factor (BDNF), transcript variant 4, mRNA as a reference-based alignment. Our alignment procedure retained 126 unique in-frame sequences.

Step 2. Recombination detection. Performed manually via RDP v5 [47], see below, the “Recombination detection” section for additional details. A recombination-free file is placed in the following folder: results/BDNF/Recombinants. For the purpose of this study, we did not detect recombination in our dataset.

Step 3. Tree inference and selection analyses. For the recombination-free fasta file, we perform maximum-likelihood phylogenetic inference via IQ-TREE [48]. Next, the recombination-free alignment and an unrooted phylogenetic tree is evaluated through a standard suite of molecular evolutionary methods. This set of selection analyses includes the following but for the sake of brevity, some of these results were not shown (essentially, most were not statistically significant or not meaningful as relevant to the evolutionary results presented here).

  • FEL: locates codon sites with evidence of pervasive positive diversifying or negative selection [44].

  • BUSTEDS: tests for gene-wide episodic selection [49].

  • MEME: locates codon sites with evidence of episodic positive diversifying selection [50].

  • aBSREL: tests if a positive selection has occurred on a proportion of branches [51].

  • SLAC: performs substitution mapping [44].

  • BGM: identifies groups of sites that are apparently coevolving [45].

  • RELAX: compare gene-wide selection pressure between the query clade and background sequences [52].

  • CFEL: comparison site-by-site selection pressure between query and background sequences [53].

  • FMM: examines model fit by permitting multiple instantaneous substitutions [54].

Step 4A. Lineage assignment and tree annotation. For the unrooted phylogenetic tree, we perform lineage discovery, via NCBI and the python package ete3 toolkit. Assigning lineages to a K (by default, K = 20) number of taxonomic groups. Here, the aim is to have a broad representation of taxonomic groups, rather than the species being heavily clustered into a single group. As a reasonable approximation, we aim for <40% of species to be assigned to any one particular taxonomic group.

Step 4B. We perform tree labeling via the hyphy-analyses/Label-Trees (REF, link) method. Resulting in one annotated tree per lineage designation. For the purpose of this study, we will only consider the following five lineages for additional analyses (Artiodactyla, Carnivora, Chiroptera, Glires, Primates) as they are the most populated lineages.

Step 5. Selection analyses on lineages. Here, the recombination-free fasta file and the set of annotated phylogenetic trees (where labeling was performed in Step 4) is provided for analysis with the RELAX and Contrast-FEL methods.

Recombination detection

Manually tested via RDP v5.5 with modified settings as follows:

  • We also included the following algorithms/analyses: RDP [55], GENECONV [56], Chimaera [57], MaxChi [58], BootScan [59] (Primary and Secondary Scan), SiScan [60] (Primary and Secondary Scan), 3Seq [61].

  • Recombination events are “accepted” in cases where three or more methods are in agreement.

  • We slightly modified default parameters, such that
    • Require topological evidence.
    • Polish breakpoints.
    • Check alignment consistency.
    • Sequences are linear.
    • List events detected by >2 methods.
  • We manually recheck all of the events via “Recheck all identified events with all methods”.

  • We manually accept events detected by >2 methods.

  • The resulting alignment was saved as a distributed alignment (with recombinant regions separated).

Recombination was not detected within our Human reference-based alignment. Therefore we used the single recombination-free alignment for analyses.

Supplementary information

Supplementary Material (232.5KB, pdf)

Author contributions

M.J.N. and A.G.L. contributed equally, with final co-authorship order determined via a competitive thumb wrestle tournament. M.J.N. was supported by an NHMRC CJ Martin Fellowship for stem cell training at the Center for Neurogenetics located at Weill Cornell Medical College of Cornell University.

Data availability

The AOC application is freely available via a dedicated GitHub repository at: https://github.com/aglucaci/AnalysisOfOrthologousCollections Raw data for this study is available on GitHub: https://github.com/aglucaci/AnalysisOfOrthologousCollections/tree/main/data/BDNF. Full results for this study include all HyPhy selection analyses JSON-formatted result files are available on GitHub: https://github.com/aglucaci/AnalysisOfOrthologousCollections/tree/main/results/BDNF.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

These authors contributed equally: Alexander G. Lucaci, Michael J. Notaras.

Supplementary information

The online version contains supplementary material available at 10.1038/s41398-022-02021-w.

References

  • 1.Notaras M, Hill R, van den Buuse M. The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy. Mol Psychiatry. 2015;20:916–30. doi: 10.1038/mp.2015.27. [DOI] [PubMed] [Google Scholar]
  • 2.Nagappan G, Lu B. Activity-dependent modulation of the BDNF receptor TrkB: mechanisms and implications. Trends Neurosci. 2005;28:464–71. doi: 10.1016/j.tins.2005.07.003. [DOI] [PubMed] [Google Scholar]
  • 3.Black IB. Trophic regulation of synaptic plasticity. J Neurobiol. 1999;41:108–18. doi: 10.1002/(SICI)1097-4695(199910)41:1&#x0003c;108::AID-NEU14&#x0003e;3.0.CO;2-U. [DOI] [PubMed] [Google Scholar]
  • 4.Yoshii A, Constantine‐Paton M. Postsynaptic BDNF‐TrkB signaling in synapse maturation, plasticity, and disease. Dev Neurobiol. 2010;70:304–22. doi: 10.1002/dneu.20765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Sakuragi S, Tominaga-Yoshino K, Ogura A. Involvement of TrkB-and p75 NTR-signaling pathways in two contrasting forms of long-lasting synaptic plasticity. Sci Rep. 2013;3:1–7. doi: 10.1038/srep03185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Horch HW, Kruttgen A, Portbury S, Katz LC. Destabilization of cortical dendrites and spines by BDNF. Neuron. 1999;23:353–64. doi: 10.1016/S0896-6273(00)80785-0. [DOI] [PubMed] [Google Scholar]
  • 7.Giza JI, Kim J, Meyer H, Anastasia A, Dincheva I, Zheng C, et al. The BDNF Val66Met prodomain disassembles dendritic spines altering fear extinction circuitry and behavior. Neuron. 2018;99:163–78.. doi: 10.1016/j.neuron.2018.05.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci. 2007;10:1089–93. doi: 10.1038/nn1971. [DOI] [PubMed] [Google Scholar]
  • 9.Angelucci F, Brene S, Mathe A. BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry. 2005;10:345–52. doi: 10.1038/sj.mp.4001637. [DOI] [PubMed] [Google Scholar]
  • 10.Kim YK, Lee H, Won S, Park E, Lee H, Lee B, et al. Low plasma BDNF is associated with suicidal behavior in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:78–85. doi: 10.1016/j.pnpbp.2006.06.024. [DOI] [PubMed] [Google Scholar]
  • 11.Notaras M, van den Buuse M. Neurobiology of BDNF in fear memory, sensitivity to stress, and stress-related disorders. Mol Psychiatry. 2020;25:2251–74. doi: 10.1038/s41380-019-0639-2. [DOI] [PubMed] [Google Scholar]
  • 12.Pivac N, Kozaric-Kovacic D, Grubisic-Ilic M, Nedic G, Rakos I, Nikolac M, et al. The association between brain-derived neurotrophic factor Val66Met variants and psychotic symptoms in posttraumatic stress disorder. World J Biol Psychiatry. 2012;13:306–11. doi: 10.3109/15622975.2011.582883. [DOI] [PubMed] [Google Scholar]
  • 13.Pitts BL, Whealin J, Harpaz-Rotem I, Duman S, Krystal J, Southwick S, et al. BDNF Val66Met polymorphism and posttraumatic stress symptoms in US military veterans: Protective effect of physical exercise. Psychoneuroendocrinol. 2019;100:198–202. doi: 10.1016/j.psyneuen.2018.10.011. [DOI] [PubMed] [Google Scholar]
  • 14.Zhang L, Benedek D, Fullerton C, Forsten R, Naifeh J, Li X, et al. PTSD risk is associated with BDNF Val66Met and BDNF overexpression. Mol Psychiatry. 2014;19:8–10. doi: 10.1038/mp.2012.180. [DOI] [PubMed] [Google Scholar]
  • 15.Notaras M, Hill R, van den Buuse M. A role for the BDNF gene Val66Met polymorphism in schizophrenia? A comprehensive review. Neurosci Biobehav Rev. 2015;51:15–30. doi: 10.1016/j.neubiorev.2014.12.016. [DOI] [PubMed] [Google Scholar]
  • 16.Gratacòs M, Gonzalez J, Mercader J, de Cid R, Urretavizcaya, Estivill X. Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol Psychiatry. 2007;61:911–22. doi: 10.1016/j.biopsych.2006.08.025. [DOI] [PubMed] [Google Scholar]
  • 17.Zakharyan R, Boyajyan A, Arakelyan A, Gevorgyan A, Mrazek F, Petrek M. Functional variants of the genes involved in neurodevelopment and susceptibility to schizophrenia in an Armenian population. Hum Immunol. 2011;72:746–8. doi: 10.1016/j.humimm.2011.05.018. [DOI] [PubMed] [Google Scholar]
  • 18.Howells D, Porritt M, Wong J, Batchelor P, Kalnins R, Hughes A, Donnan J, et al. Reduced BDNF mRNA expression in the Parkinson’s disease substantia nigra. Exp Neurol. 2000;166:127–35. doi: 10.1006/exnr.2000.7483. [DOI] [PubMed] [Google Scholar]
  • 19.Palasz E, Wysocka A, Gasiorowska A, Chalimoniuk M, Niewiadomski W, Niewiadomski G. BDNF as a promising therapeutic agent in Parkinson’s disease. Int J Mol Sci. 2020;21:1170. doi: 10.3390/ijms21031170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Correia C, Coutinho A, Sequeira A, Sousa I, Venda L, Almeida J, et al. Increased BDNF levels and NTRK2 gene association suggest a disruption of BDNF/TrkB signaling in autism. Genes Brain Behav. 2010;9:841–8. doi: 10.1111/j.1601-183X.2010.00627.x. [DOI] [PubMed] [Google Scholar]
  • 21.Ricci S, Businaro R, Ippoliti F, Lo Vasco V, Massoni F, Onofri E, et al. Altered cytokine and BDNF levels in autism spectrum disorder. Neurotox Res. 2013;24:491–501. doi: 10.1007/s12640-013-9393-4. [DOI] [PubMed] [Google Scholar]
  • 22.Tsai S-J. Is autism caused by early hyperactivity of brain-derived neurotrophic factor? Med Hypotheses. 2005;65:79–82. doi: 10.1016/j.mehy.2005.01.034. [DOI] [PubMed] [Google Scholar]
  • 23.Massa SM, Yang T, Xie Y, Shi J, Bilgen M, Joyce J, et al. Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. J Clin Investig. 2010;120:1774–85. doi: 10.1172/JCI41356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Kingwell K. BDNF copycats. Nat Rev Drug Disco. 2010;9:433.. doi: 10.1038/nrd3190. [DOI] [PubMed] [Google Scholar]
  • 25.Chen B, Dowlatshahi D, MacQueen G, Wang J, Young L. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry. 2001;50:260–5. doi: 10.1016/S0006-3223(01)01083-6. [DOI] [PubMed] [Google Scholar]
  • 26.Björkholm C, Monteggia L. BDNF–a key transducer of antidepressant effects. Neuropharmacol. 2016;102:72–79. doi: 10.1016/j.neuropharm.2015.10.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Anastasia A, Deinhardt K, Chao M, Will N, Irmady K, Lee F, et al. Val66Met polymorphism of BDNF alters prodomain structure to induce neuronal growth cone retraction. Nat Comm. 2013;4:1–13. doi: 10.1038/ncomms3490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Glerup S, Bolcho U, Molgaard S, Boggild S, Vaegter C, Smith A, et al. SorCS2 is required for BDNF-dependent plasticity in the hippocampus. Mol Psychiatry. 2016;21:1740–51. doi: 10.1038/mp.2016.108. [DOI] [PubMed] [Google Scholar]
  • 29.Notaras M, van den Buuse M. Brain-derived neurotrophic factor (BDNF): novel insights into regulation and genetic variation. Neuroscientist. 2019;25:434–54. doi: 10.1177/1073858418810142. [DOI] [PubMed] [Google Scholar]
  • 30.Pruunsild P, Kazantseva A, Aid T, Palm K, Timmusk T. Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics. 2007;90:397–406. doi: 10.1016/j.ygeno.2007.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Lipovich L, Dachet F, Cai J, Bagla S, Balan K, Jia H, et al. Activity-dependent human brain coding/noncoding gene regulatory networks. Genetics. 2012;192:1133–48. doi: 10.1534/genetics.112.145128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Chiaruttini C, Vicario A, Li Z, Baj G, Braiuca P, Wu Y, et al. Dendritic trafficking of BDNF mRNA is mediated by translin and blocked by the G196A (Val66Met) mutation. Proc Nat Acad Sci USA. 2009;106:16481–6. doi: 10.1073/pnas.0902833106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Chen Z-Y, Leraci A, Teng H, Dall H, Meng C, Herrera D, Nykjaer A, et al. Sortilin controls intracellular sorting of brain-derived neurotrophic factor to the regulated secretory pathway. J Neurosci. 2005;25:6156–66. doi: 10.1523/JNEUROSCI.1017-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Gray K, Ellis V. Activation of pro-BDNF by the pericellular serine protease plasmin. FEBS Lett. 2008;582:907–10. doi: 10.1016/j.febslet.2008.02.026. [DOI] [PubMed] [Google Scholar]
  • 35.del Carmen Cardenas-Aguayo M, Kazim S, Grundke-Iqbal I, Iqbal K. Neurogenic and neurotrophic effects of BDNF peptides in mouse hippocampal primary neuronal cell cultures. PLoS ONE. 2013;8:E53596. doi: 10.1371/journal.pone.0053596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Maisonpierre PC, Le Beau M, Espinosa R, Ip N, Belluscio L, de la Monte S, et al. Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations. Genomics. 1991;10:558–68. doi: 10.1016/0888-7543(91)90436-I. [DOI] [PubMed] [Google Scholar]
  • 37.Finn RD, Coggill P, Eberhardt R, Eddy S, Mistry J, Mitchell A, et al. The Pfam protein families database: towards a more sustainable future. Nucleic Acids Res. 2016;44(D1):D279–85. doi: 10.1093/nar/gkv1344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Rodriguez-Tebar A, Dechant G, Barde Y. Binding of brain-derived neurotrophic factor to the nerve growth factor receptor. Neuron. 1990;4:487–92. doi: 10.1016/0896-6273(90)90107-Q. [DOI] [PubMed] [Google Scholar]
  • 39.Castellani V, Bolz J. Opposing roles for neurotrophin-3 in targeting and collateral formation of distinct sets of developing cortical neurons. Development. 1999;126:3335–45. doi: 10.1242/dev.126.15.3335. [DOI] [PubMed] [Google Scholar]
  • 40.Kuczewski N, Porcher C, Lessmann V, Medina I, Gaiarsa JL. Activity-dependent dendritic release of BDNF and biological consequences. Mol Neurobiol. 2009;39:37–49. doi: 10.1007/s12035-009-8050-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Chen Z-Y, Patel P, Sant G, Meng C, Teng K, Hempstead B, et al. Variant brain-derived neurotrophic factor (BDNF)(Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci. 2004;24:4401–11. doi: 10.1523/JNEUROSCI.0348-04.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Kumar S, Stecher G, Suleski M, Hedges B. TimeTree: a resource for timelines, timetrees, and divergence times. Mol Biol Evol. 2017;34:1812–9. doi: 10.1093/molbev/msx116. [DOI] [PubMed] [Google Scholar]
  • 43.Hedges BS, Dudley J, Kumar S. TimeTree: a public knowledge-base of divergence times among organisms. Bioinformatics, 2006;22:2971–2. doi: 10.1093/bioinformatics/btl505. [DOI] [PubMed] [Google Scholar]
  • 44.Kosakovsky Pond SL, Frost SDW. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol Biol Evol. 2005;22:1208–22. doi: 10.1093/molbev/msi105. [DOI] [PubMed] [Google Scholar]
  • 45.Poon AFY, Lewis FI, Frost SDW, Kosakovsky Pond SL. Spidermonkey: rapid detection of co-evolving sites using Bayesian graphical models. Bioinformatics. 2008;24:1949–50. doi: 10.1093/bioinformatics/btn313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Kosakovsky Pond SL, Poon AFY, Velazquez R, Weaver S, Helper LN, Murrell B, et al. HyPhy 2.5—A customizable platform for evolutionary hypothesis testing using phylogenies. Mol Biol Evolution. 2020;37:295–9. doi: 10.1093/molbev/msz197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Martin DP, Murrell B, Golden M, Khoosal A, Muhire B. RDP4: detection and analysis of recombination patterns in virus genomes. Virus Evol. 2015;1:vev003.. doi: 10.1093/ve/vev003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Minh BQ, Schmidt HA, Chernomor O, Schremph D, von Haeseler A, et al. IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era. Mol Biol Evol. 2020;37:530–1534. doi: 10.1093/molbev/msaa015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Wisotsky SR, Kosakovsky Pond SL, Shank SD, Muse SV. Synonymous site-to-site substitution rate variation dramatically inflates false positive rates of selection analyses: ignore at your own peril. Mol Biol Evol. 2020;37:2430–9. doi: 10.1093/molbev/msaa037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Murrell B, Wertheim JO, Moola S, Weighill T, Scheffler K, Kosakovsky Pond SL. Detecting individual sites subject to episodic diversifying selection. PLoS Genet. 2012;8:e1002764. doi: 10.1371/journal.pgen.1002764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Smith MD, Wertheim JO, Weaver S, Murrell B, Scheffler K, Kosakovsky Pond SL. Less is more: an adaptive branch-site random effects model for efficient detection of episodic diversifying selection. Mol Biol Evol. 2015;32:1342–53. doi: 10.1093/molbev/msv022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Wertheim JO, Murrell B, Smith MD, Kosakovsky Pond SL, Scheffler K. RELAX: detecting relaxed selection in a phylogenetic framework. Mol Biol Evol. 2015;32:820–32. doi: 10.1093/molbev/msu400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Kosakovsky Pond SL, Wisotsky SR, Escalante A, Magalis BR, Weaver S. Contrast-FEL-A test for differences in selective pressures at individual sites among clades and sets of branches. Mol Biol Evol. 2021;38:1184–98. doi: 10.1093/molbev/msaa263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Lucaci AG, Wisotsky SR, Shank SD, Weaver S, Kosakovsky Pond SL. Extra base hits: widespread empirical support for instantaneous multiple-nucleotide changes. PLoS ONE. 2021;16:e0248337. doi: 10.1371/journal.pone.0248337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Martin D, Rybicki E. RDP: detection of recombination amongst aligned sequences. Bioinformatics. 2000;16:562–3. doi: 10.1093/bioinformatics/16.6.562. [DOI] [PubMed] [Google Scholar]
  • 56.Padidam M, Sawyer S, Fauquet CM. Possible emergence of new geminiviruses by frequent recombination. Virology. 1999;265:218–25. doi: 10.1006/viro.1999.0056. [DOI] [PubMed] [Google Scholar]
  • 57.Posada D, Crandall KA. Evaluation of methods for detecting recombination from DNA sequences: computer simulations. Proc Natl Acad Sci USA. 2001;98:13757–62. doi: 10.1073/pnas.241370698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Maynard Smith J. Analyzing the mosaic structure of genes. J Mol Evol. 1992;34:126–9. doi: 10.1007/BF00182389. [DOI] [PubMed] [Google Scholar]
  • 59.Martin DP, Posada D, Crandall KA, Williamson C. A modified bootscan algorithm for automated identification of recombinant sequences and recombination breakpoints. AIDS Res Hum Retroviruses. 2005;21:98–102. doi: 10.1089/aid.2005.21.98. [DOI] [PubMed] [Google Scholar]
  • 60.Gibbs MJ, Armstrong JS, Gibbs AJ. Sister-scanning: a Monte Carlo procedure for assessing signals in recombinant sequences. Bioinformatics. 2000;16:573–82. doi: 10.1093/bioinformatics/16.7.573. [DOI] [PubMed] [Google Scholar]
  • 61.Lam HM, Ratmann O, Boni MF. Improved algorithmic complexity for the 3SEQ recombination detection algorithm. Mol Biol Evolution. 2018;35:247–51. doi: 10.1093/molbev/msx263. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Material (232.5KB, pdf)

Data Availability Statement

The AOC application is freely available via a dedicated GitHub repository at: https://github.com/aglucaci/AnalysisOfOrthologousCollections Raw data for this study is available on GitHub: https://github.com/aglucaci/AnalysisOfOrthologousCollections/tree/main/data/BDNF. Full results for this study include all HyPhy selection analyses JSON-formatted result files are available on GitHub: https://github.com/aglucaci/AnalysisOfOrthologousCollections/tree/main/results/BDNF.


Articles from Translational Psychiatry are provided here courtesy of Nature Publishing Group

RESOURCES